Is right lung adenocarcinoma a very difficult disease? what do you think?

Lung adenocarcinoma is a common pathological type of lung cancer, which is generally curable. Of course, it also depends on the size and stage of lung adenocarcinoma, which is an important factor to determine the prognosis. For example, in the early stage of lung adenocarcinoma, surgical lobectomy can achieve a radical effect, and some patients do not need adjuvant chemotherapy after surgery. If there is local infiltration, or the postoperative pathological staging is not very early, it belongs to the middle and late stage. This condition requires postoperative adjuvant chemotherapy. Generally, pemetrexed and platinum are the main first-line chemotherapy, and radiotherapy and other comprehensive treatments can be combined with chemotherapy. Lung adenocarcinoma still has some targeted drugs to choose from. We can do genetic testing first. If there is a gene mutation like EGFR, there are still many treatments to choose from, so it is possible to cure it. Don't give up treatment.

The best treatment for right lung adenocarcinoma mainly depends on the stage of lung adenocarcinoma. If it is early lung adenocarcinoma, that is, the tumor is less than 3cm, and there is no hilar lymph node metastasis, mediastinal lymph node metastasis, supraclavicular lymph node metastasis or distant metastasis, such as bone metastasis and brain metastasis, surgical treatment is selected. Whether postoperative adjuvant therapy is needed after surgical resection depends on postoperative pathology. Preoperative evaluation can be performed by radical surgical resection, and postoperative pathological diagnosis is early, and postoperative adjuvant radiotherapy, chemotherapy or targeted therapy can be exempted.

If it is locally advanced lung adenocarcinoma or advanced lung adenocarcinoma, that is, the tumor is relatively large and complicated with mediastinal lymph node metastasis or supraclavicular lymph node metastasis, brain metastasis, liver metastasis and so on. At this time, we must first look at whether there is a gene mutation in lung adenocarcinoma. If there is a genetic mutation, targeted drugs can be used. If there is no gene mutation, immune checkpoint inhibitors or combined chemotherapy can be used for treatment. In a word, the best treatment for right lung adenocarcinoma is mainly combined with pathological staging and gene mutation.